XML 50 R35.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders’ Equity (Tables)
 12 Months Ended
Dec. 31, 2024
Subsidiary, Sale of Stock [Line Items]  
Schedule of Fair Value of Instruments Issued in Offering

 

   Allocated Amount 
Common shares  $72,108 
Prefunded warrants   2,398,831 
Common warrants   3,819,274 
Net proceeds  $6,290,213 
Schedule of Fair value of Warrants Valuation Assumption

In determining the fair values of the Pre-Funded Warrants, Common Warrants, and Placement Agent Warrants, the Company used a Black-Scholes Option Pricing model with the following assumptions:

 

    Pre-Funded Warrants   Common Warrants   Placement Agent Warrants
Expected volatility   100%   103% - 121%   103%
Contractual term   1 year   1½ - 5½ years   5½ years
Risk-free interest rate   5.51%   4.57% - 5.51%   4.57%
Expected dividend yield   0%   0%   0%
Insider Private Placement [Member]  
Subsidiary, Sale of Stock [Line Items]  
Schedule of Fair Value of Instruments Issued in Offering

Schedule of Fair Value of Instruments Issued in Offering 

   Allocated Amount 
Common Shares  $258,000 
Pre-Funded Warrants  $321,000 
Regular Warrants  $470,000 
Net Proceeds  $1,049,000 
Schedule of Fair value of Warrants Valuation Assumption

In determining the fair values of the Pre-Funded Warrants, Regular Warrants, and Placement Agent Warrants, the Company used a Black-Scholes Option Pricing model with the following assumptions:

 

Schedule of Fair value of Warrants Valuation Assumption  

   Pre-Funded Warrants  Regular Warrants  Placement Agent Warrants
Expected volatility  134%  96%  99%
Contractual/expected term  1 month  7 years  5 years
Risk-free interest rate  5.53%  3.91%  3.89%
Expected dividend yield  0%  0%  0%